Life projects: the transformative potential of direct-acting antiviral treatment for hepatitis C among people who inject drugs.

Background And Objectives: People who inject drugs (PWID) are disproportionately affected by chronic hepatitis C (HCV) in high-income countries. The advent of direct-acting antivirals (DAAs) makes treatment of this underserved population more possible than ever. The dearth of programs adapted to the needs of PWID and stigma associated with drug use and chronic HCV pose significant barriers to the effective uptake of treatment among this population.

[Biological alternatives to antibiotics].

The paper presents the characteristics of biological alternatives to antibiotics, that are bacteriophages, bacterial cell wall hydrolases and antimicrobial alternatives. Those substances are promising candidates that can successfully replace a lot of chemioterapeutics at the time of antibiotic-resistance.